Liya Ding, PhD | Meet a Scientist
Dr. Liya Ding, of Dana-Farber Cancer Institute, is a 2021 recipient of OCRA’s Liz Tilberis Early Career Award. With her project, “Targeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer,” … Continued
News
Bojana Stefanovska, PhD | Meet a Scientist
Dr. Bojana Stefanovska, at University of Minnesota Twin Cities, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award. Her project, “APOBEC3B and DNA Repair as Synthetic … Continued
A Thanksgiving Message from Audra Moran, President & CEO
Dear Friends, I hope this finds you all well, staying safe, and enjoying preparations for a lovely holiday. Whether you’re gathering with loved ones or holding them in your heart as … Continued
The Overview: November 2021
As we head into the Thanksgiving holiday, we have much to be thankful for … an embracing and strong survivor community, supporters who remain ever committed to the cause, and … Continued
Action Alert: Urge Your Elected Officials to Co-Sponsor the DIVERSE Trials Act
Clinical trials are fundamental to the discovery of new and better therapies in the fight against ovarian cancer. Yet enrollment and widespread availability remain a challenge. To address both financial … Continued
OCRA-Funded Study Points to New Approach to Improve Ovarian Cancer Treatment
The following is a press release from University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, and Magee-Womens Research Institute PITTSBURGH, Nov. 12, 2021 – Immune checkpoint inhibitors are a … Continued
The Overview: October 2021
Have we got a roundup in store! You heard from us a lot in September (thanks to you, we surpassed our Ovarian Cancer Awareness Month fundraising goal!) and there’s still … Continued
Join Us: OCRA’s Virtual Fall Advocacy Day
November 15-16, 2021 | Register Today! Are you passionate about issues affecting the ovarian cancer community? Now is your chance to have your voice heard at the highest levels — … Continued
Finding the Story in the Data | Meet a Scientist
Sridevi Challa, PhD, an OCRA grantee at UT Southwestern, is on the receiving end of some major accolades. She is the lead author of a study that dozens of news … Continued
OCRA-Funded Study Identifies Role of Deubiquitinating Enzyme in Ovarian Cancer Progression
OCRA grantee Dr. Sumegha Mitra of Indiana University and colleagues have identified the mechanism by which a specific deubiquitinating enzyme known as UCHL1 promotes the growth of high-grade serous ovarian cancer in … Continued
Groundbreaking Initiative Seeks to Accelerate Development of New Treatments with OCRA’s Support
LOS ANGELES – (BUSINESS WIRE)–Global Coalition for Adaptive Research (GCAR) announces a new clinical trial initiative, Ovarian CanceRxTM. This innovative trial, referred to as an adaptive platform trial, is designed to … Continued
Survey: Medical Care During COVID
OCRA is conducting a survey to gauge patient response to the expansion of telehealth in response to the pandemic. Since the onset of the COVID-19 pandemic, telehealth has been growing in popularity. … Continued